MARKET

ATRS

ATRS

Antares Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.720
-0.170
-3.48%
Closed 18:55 12/09 EST
OPEN
4.810
PREV CLOSE
4.890
HIGH
4.861
LOW
4.530
VOLUME
2.93M
TURNOVER
--
52 WEEK HIGH
5.13
52 WEEK LOW
2.530
MARKET CAP
770.43M
P/E (TTM)
-1430.3030
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ATRS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ATRS News

  • 5 Safe And Cheap Dividend Stocks To Invest (December 2019)
  • Seeking Alpha - Article.2d ago
  • Top Holdings Of Dividend ETFs (Part 2: The Top 7 By Sector In November 2019)
  • Seeking Alpha - Article.2d ago
  • Comcast: Undervalued After Recent Pullback
  • Seeking Alpha - Article.3d ago
  • Bernie Sanders unveils plan to boost broadband access, break up internet and cable titans
  • CNBC.com.3d ago

More

Industry

Medical Equipment, Supplies & Distribution
-1.55%
Healthcare Equipment & Supplies
-1.27%

Hot Stocks

Name
Price
%Change

About ATRS

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.
More

Webull offers Antares Pharma Inc (ATRS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.